Clinical Trials

148 enrolled

Phase 2/3 Active not recruiting

Waldenstrom Macroglobulinemia

NCT02641847 2024-01-25

TA(E)C-GP Versus A(E)C-T for the High Risk TNBC Patients and Validation of the mRNA-lncRNA Signature

503 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT01949129 2024-01-16

Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia

1,800 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03759093 2023-09-06

CURATE.AI Optimized Modulation for Multiple Myeloma

20 enrolled

Plasma cell

Multiple Myeloma

NCT00096460 2023-01-05

BMT CTN 0202

30 enrolled 5 charts

Phase 2/3 Active not recruiting

Lymphoma, Follicular

NCT01057069 2022-10-12

neo-TN

310 enrolled

Breast Neoplasms

NCT00177047 2021-11-09

Autologous Transplant for Multiple Myeloma

363 enrolled 25 charts

Plasma cell

Multiple Myeloma

NCT00003816 2021-08-13

Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer

Classical hematologyDermatologicLymphoidMyeloidOther hematologic neoplasmSarcoma

361 enrolled 16 charts

Congenital Abnormalities, Anemia, Aplastic, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Blast Crisis, Burkitt Lymphoma, Immunoblastic Lymphadenopathy, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Mycosis Fungoides, Myelodysplastic Syndromes, Myeloproliferative Disorders, Neoplasms, Polycythemia Vera, Sezary Syndrome, Thrombocythemia, Essential, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Biphenotypic, Acute, Leukemia, Prolymphocytic, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Leukemia, Large Granular Lymphocytic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Dendritic Cell Sarcoma, Interdigitating, Primary Myelofibrosis, Intraocular Lymphoma

NCT04576143 2021-08-12

Efficacy and Safety of Dose-dense Chemotherapy (ddEC-ddP) for Neoadjuvant Chemotherapy of HER2-negative Breast Cancer

260 enrolled

HER2-negative Breast Cancer

NCT04753177 2021-02-15

The Neoadjuvant Combined Hormone Therapy in Premenopausal Women With Locally Advanced ER+/HER2- Breast Cancer

120 enrolled

The Neoadjuvant Therapy

NCT00448266 2021-01-22

Intensified IAA With PBPC Support in Breast Tumors With Evidence of a HRD

12 enrolled

Breast Neoplasms

NCT02671708 2020-03-03

IDA+BUCY vs BUCY Conditioning Regimen for Intermediate-risk AML Undergoing Auto-HSCT

Other hematologic neoplasm

153 enrolled

Leukemia, Myeloid, Acute

NCT03385096 2020-02-25

Mel vs BUCY+VP-16 Conditioning Regimen for MM Undergoing Auto-HSCT

122 enrolled

Plasma cell

Multiple Myeloma

NCT04123392 2019-10-10

Decitabine + BUCY vs BUCY Conditioning Regimen for TP53+ Myeloid Tumors Undergoing Allo-HSCT

196 enrolled

Other neoplasm

TP53

NCT04098653 2019-09-23

Decitabine + BUCY vs BUCY Conditioning Regimen for Myeloid Tumors Undergoing Allo-HSCT

196 enrolled

Other neoplasm

Allogeneic Hematopoietic Stem Cell Transplantation

NCT01907529 2019-08-09

TENDENCY

300 enrolled

Breast Neoplasms

NCT03818334 2019-02-01

Post Transplant Cyclophosphamide in Matched Unrelated Donor Stem Cell Transplantation for Hematological Malignancies

Other hematologic neoplasm

50 enrolled

Graft vs Host Disease, Virus Diseases, Hematologic Neoplasms

NCT00641095 2018-10-31

MCLPIII

370 enrolled

Lymphoma, Lymphoma, Mantle-Cell

NCT03564704 2018-06-21

Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult T-LBL/ALL

80 enrolled

Leukemia, Leukemia, T-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03553238 2018-06-12

Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult ETP-ALL

70 enrolled

Leukemia, Leukemia, T-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00176839 2017-12-05

Stem Cell Transplantation for Hematological Malignancies

11 enrolled 12 charts

Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03349177 2017-11-21

Pathological Complete Response Rate in Locally Advanced Breast Cancer With FEC, EC-T, or TC as Neoadjuvant Chemotherapy

200 enrolled

Breast Neoplasms

NCT03229616 2017-10-12

BUCY+VP-16 vs BUCY Conditioning Regimen for DLBCL Undergoing Auto-HSCT

122 enrolled

Lymphoma, Large B-Cell, Diffuse

NCT02871869 2017-07-17

Cinobufacini Tablets Combined With Chemotherapeutic Protocol in Treatment of Diffuse Large B Cell Lymphoma

316 enrolled

Lymphoma, Large B-Cell, Diffuse

NCT01204437 2016-02-10

ICE-II

400 enrolled

Breast Neoplasms

NCT00934739 2015-02-25

A Study of High-Risk Oral Cavity Cancer

150 enrolled

Head & Neck

Mouth Neoplasms

NCT00003187 2010-02-24

Bone Marrow Transplantation in Treating Patients With Leukemia, Myelodysplasia, or Lymphoblastic Lymphoma

Classical hematologyLymphoidMyeloidOther hematologic neoplasm

19 enrolled

Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Leukemia, Lymphoma, Myelodysplastic Syndromes, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00525642 2007-09-06

Study of Suitable Schedule of Docetaxel,Anthracycline and Cyclophosphamide in Adjuvant Therapy of Beast Cancer

603 enrolled

Breast Neoplasms

NCT00169130 2007-07-13

ACVBP Followed by ASCT in Patients With BCL-2 Positive Diffuse Large B-Cell Lymphoma

300 enrolled